InsiderTrades

Form 4 for SNWV SANUWAVE Health, Inc.

Accepted 2023-11-21 00:00:00 ET · period of report 2023-11-17 · accession 0000919574-23-006492 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2023-11-21 2023-11-17 SNWV MANCHESTER MANAGEMENT PR, LLC Dir by Deputization C - Cnv Deriv $0.04 +11.50M 14.00M +460% +$460.0K
DI 2023-11-21 2023-11-17 SNWV MANCHESTER MANAGEMENT PR, LLC Dir by Deputization C - Cnv Deriv — 0 0 New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.001 2023-11-17 C A 11,500,000 $0.04 14,000,000 I See footnote — — (F1) Pursuant to the terms of the Future Advance Convertible Promissory Note issued on November 15, 2022, all principal and accrued and unpaid interest due as of the maturity date, November 15, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share. (F2) The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of JEB Partners, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose
2 Derivative Future Advance Convertible Promissory Note 2023-11-17 C D — $0.04 0 I See footnote $0.04 · 2022-11-15 to — 11,500,000 Common Stock, par value $0.001 (F2) The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of JEB Partners, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose (F1) Pursuant to the terms of the Future Advance Convertible Promissory Note issued on November 15, 2022, all principal and accrued and unpaid interest due as of the maturity date, November 15, 2023, has been converted by the Issuer into shares of Common Stock of the Issuer at a conversion price of $0.04 per share.